Dr. Susan Girois hosted the conversation discussing several topics relating to vaccines, including how they are developed and tested.

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...

Changes are on the way for COVID vaccines after the FDA adjusted the standard of evidence needed to approve shots for the general public.

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk, ...

The FDA announces changes for who's eligible for the COVID-19 vaccine. Plus, should musicians shut up & sing or tell critics ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...